PGEN Precigen Inc
Company Analysis
Latest News
🔴 Precigen is trading 4.39% down today amid risk-off trading as investors reassess AI spending
Precigen is trading at $6.31, down 4.39% on October 22, 2026, amid broader risk-off sentiment. - No company-specific catalyst was identified in the news flow...
🟢 Precigen is trading 4.05% up today amid broader biotech-sector strength
Precigen is trading 4.05% up at $6.93, amid biotech-sector strength. - No new company-specific announcement or catalyst for October 20 was identified; the...
🟢 Precigen is trading 4.15% up today as biotech stocks rallied
Precigen is trading at $6.65, up +4.15%, with biotech-sector strength providing the clearest context for the gain. - No new company-specific announcement or...
🔴 Precigen is trading 10.56% down today amid broader technology-led selling and biotech weakness
Precigen is trading at $6.43, down 10.56%, amid broader technology-led selling and biotech weakness, with no verified company-specific catalyst. - No verified...
🔴 Precigen is trading 4.24% down today amid biotech-sector weakness
Precigen is trading 4.24% down at $6.89, with biotech-sector weakness potentially weighing on shares; no verified new company-specific announcement has been...
🔴 Precigen is trading 10.25% down — catalyst unclear
Precigen is trading 10.25% down at $7.67, with no clear company-specific catalyst identified. - Its press-release page lists the September 21 FDA platform...
🔴 Precigen is trading 4.45% down
Precigen is trading 4.45% lower at $8.16, with no specific catalyst confirmed in the available evidence. - The company’s press-release page lists its latest...
🔴 Precigen is trading 4.03% down — no company-specific explanation identified
Precigen is trading 4.03% lower at $8.21 on October 1, 2026, with no company-specific announcement explaining the decline identified in available reporting. -...
🟢 Precigen is trading 10% up today as cooler inflation lifts Nasdaq
Precigen is trading at $8.88, up 10.37%, amid supportive broader-market sentiment after cooler-than-expected inflation boosted hopes the Fed might delay rate...
🟢 Precigen is trading 4.3% up today with no company-specific catalyst identified
Precigen is trading 4.29% higher at $8.39; no company-specific catalyst dated September 30 was found, while broader-market gains may be supportive. - The...
🟢 Precigen is trading 5% up today after B. Riley initiated Buy coverage
Precigen is trading at $8.08, up 4.94% on September 25, 2026, after B. Riley initiated coverage with a Buy rating and a $12 price target. - The target implies...
🟢 Precigen is trading 5% up today in pre-market after B. Riley initiated Buy-rated coverage
Precigen is trading 5.02% up at $8.09 after B. Riley initiated coverage on September 25, 2026, with a Buy rating and a $12 price target. - The target implies...
🟢 Precigen is trading 4.84% up in after-hours trading as investors digest FDA platform technology designation
Precigen is trading 4.84% higher at $7.80 in after-hours trading as investors digest the FDA’s September 21, 2026 designation of its AdenoVerse...
🔴 Precigen is trading 4.1% down today as oil prices and Treasury yields rise
Precigen is trading 4.1% down at $7.57 as broader market sentiment weakens. - The Nasdaq Composite is down 1.05%, as investors respond to higher oil prices,...
🟢 Precigen rises 4.1% — Biotech Sector Rallies on Major AI Collaboration Deal and Positive Clinical News
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is trading higher, driven by a...
Precigen hits 52-week high, on track for first profitable year
Precigen Inc. shares reached a new 52-week high of $7.74 USD on Thursday. The biotechnology company specializes in developing gene and cell therapies. The...
🟢 Precigen is trading 4.45% up today as biotech ETF XBI gains 2.55%
Precigen is trading 4.45% up now at $7.75, with the move appearing primarily sector-driven as biotech ETF XBI gains 2.55%. - Precigen rose 6.21% on September...
🟢 Precigen is trading 5% up today despite no clear company-specific announcement
Precigen is trading 5.15% up now at $7.36, with no clear company-specific announcement identified on September 16, 2026. - Latest identified results were...